Brain and cerebrovascular aging - New mechanisms and insights

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 11, 2014, Pages 1307-1310

  Ungvari, Zoltan ^a   Sonntag, William E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL; BIOLOGICAL MODEL; BRAIN; BRAIN CIRCULATION; HUMAN; PHYSIOLOGY; PSYCHOLOGY; VASCULARIZATION;

AGING; ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; HUMANS; MODELS, NEUROLOGICAL;

EID: 84911090939     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu187     Document Type: Editorial

References (53)

1. Deak F Neuronal Vesicular Trafficking and Release in Age-Related Cognitive Impairment. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu061
2. Farkas E, Bari F Spreading Depolarization in the Ischemic Brain: Does Aging Have an Impact? J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu066
3. Masser DR, Bixler GV, Brucklacher RM, et al.et al. Hippocampal Subregions Exhibit Both Distinct and Shared Transcriptomic Responses to Aging and Nonneurodegenerative Cognitive Decline. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/ gerona/glu091
4. Pirger Z, Naskar S, Laszlo Z, Kemenes G, Reglodi D, Kemenes I Reversal of Age-Related Learning Deficiency by the Vertebrate PACAP and IGF-1 in a Novel Invertebrate Model of Aging: The Pond Snail (Lymnaea stagnalis). J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu068
5. Tucsek Z, Toth P, Tarantini S, et al.et al. Aging Exacerbates Obesity-induced Cerebromicrovascular Rarefaction, Neurovascular Uncoupling, and Cognitive Decline in Mice. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu080
6. Yan H, Mitschelen M, Toth P, et al.et al. Endothelin-1-Induced Focal Cerebral Ischemia in the Growth Hormone/IGF-1 Deficient Lewis Dwarf Rat. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/ glu118
7. Cheng C, Lin CH, Tsai YW, Tsai CJ, Chou PH, Lan TH Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/ glu073
8. Clark DJ, Christou EA, Ring SA, Williamson JB, Doty L Enhanced Somatosensory Feedback Reduces Prefrontal Cortical Activity During Walking in Older Adults. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu125
9. Davis BJ, Vidal JS, Garcia M, et al.et al. The Alcohol Paradox: Lightto-Moderate Alcohol Consumption, Cognitive Function, and Brain Volume. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/ glu092
10. Holtzer R, Epstein N, Mahoney JR, Izzetoglu M, Blumen HM Neuroimaging of Mobility in Aging: A Targeted Review. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu052
11. Hugenschmidt CE, Burdette JH, Morgan AR, Williamson JD, Kritchevsky SB, Laurienti PJ Graph Theory Analysis of Functional Brain Networks and Mobility Disability in Older Adults. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu048
12. Koyama A, Houston DK, Simonsick EM, et al.et al. Association Between the Mediterranean Diet and Cognitive Decline in a Biracial Population. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu097
13. Lambiase MJ, Gabriel KP, Kuller LH, Matthews KA. Sleep and executive function in older women: The moderating effect of physical activity. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu038
14. Passaro A, Dalla Nora E, Morieri ML, et al.et al. Brain-Derived Neurotrophic Factor Plasma Levels: Relationship With Dementia and Diabetes in the Elderly Population. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu028
15. Pedersen MM, Holt NE, Grande L, et al.et al. Mild Cognitive Impairment Status and Mobility Performance: An Analysis From the Boston RISE Study. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu063
16. Welmer AK, Rizzuto D, Qiu C, Caracciolo B, Laukka EJ Walking Speed, Processing Speed, and Dementia: A Population-Based Longitudinal Study. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/ gerona/glu047
17. VanSwearingen JM, Studenski SA Aging, Motor Skill and the Energy Cost of Walking: Implications for the Prevention and Treatment of Mobility Decline in Older Persons. J Gerontol A Biol Sci Med Sci. 2014: JGMS-2013-SA-2548
18. Montero-Odasso M, Oteng-Amoako A, Speechley M, et al.et al. The Motor Signature of Mild Cognitive Impairment: Results from the Gait and Brain Study. J Gerontol A Biol Sci Med Sci. 2014: JGMS-2013-RES-2550
19. Killane I, Donoghue OA, Savva GM, Cronin H, Kenny RA, Reilly RB Relative Association of Processing Speed, Short Term Memory and Sustained Attention with Task on Gait Speed: A Study of Community Dwelling People Fifty Years and Older. J Gerontol A Biol Sci Med Sci. 2014: JGMS-2013-RES-2552.R2012
20. Allali G, van der Meulen M, Beauchet O, Rieger SW, Vuilleumier P, Assal F The Neural Basis of Age-Related Changes in Motor Imagery of Gait: An fMRI Study. J Gerontol A Biol Sci Med Sci. 2013. DOI:10.1093/gerona/glt207
21. Deak F, Sonntag WE. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J Gerontol A Biol Sci Med Sci. 2012;67:611-625. DOI:10.1093/gerona/gls118
22. Sonntag WE, Deak F, Ashpole N, et al.et al. Insulin-like growth factor-1 in CNS and cerebrovascular aging. Front Aging Neurosci. 2013;5:27. DOI:10.3389/fnagi.2013.00027
23. Sonntag WE, Csiszar A, deCabo R, Ferrucci L, Ungvari Z. Diverse roles of growth hormone and insulin-like growth factor-1 in mammalian aging: Progress and controversies. J Gerontol A Biol Sci Med Sci. 2012;67:587-598. DOI:10.1093/gerona/gls115
24. Yuan R, Gatti DM, Krier R, et al.et al. Genetic Regulation of Female Sexual Maturation and Longevity Through Circulating IGF1. J Gerontol A Biol Sci Med Sci. 2014. DOI:10.1093/gerona/glu114
25. Bailey-Downs LC, Mitschelen M, Sosnowska D, et al.et al. Liverspecific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: A novel model of vascular aging. J Gerontol A Biol Sci Med Sci. 2012;67: 313-329. DOI:10.1093/gerona/glr164
26. Bailey-Downs LC, Sosnowska D, Toth P, et al.et al. Growth hormone and IGF-1 deficiency exacerbate high-fat diet-induced endothelial impairment in obese Lewis dwarf rats: Implications for vascular aging. J Gerontol A Biol Sci Med Sci. 2012;67:553-564. DOI:10.1093/ gerona/glr197
27. Berryman DE, Lubbers ER, Magon V, List EO, Kopchick JJ. A dwarf mouse model with decreased GH/IGF-1 activity that does not experience life-span extension: Potential impact of increased adiposity, leptin, and insulin with advancing age. J Gerontol A Biol Sci Med Sci. 2014;69:131-141. DOI:10.1093/gerona/glt069
28. Brioche T, Kireev RA, Cuesta S, et al.et al. Growth hormone replacement therapy prevents sarcopenia by a dual mechanism: Improvement of protein balance and of antioxidant defenses. J Gerontol A Biol Sci Med Sci. 2013.DOI:10.1093/gerona/glt187
29. Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. Aging, atherosclerosis, and IGF-1. J Gerontol A Biol Sci Med Sci. 2012;67:626-639. DOI:10.1093/gerona/gls102
30. Lorenzini A, Salmon AB, Lerner C, et al.et al. Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span. J Gerontol A Biol Sci Med Sci. 2014;69:410-419. DOI:10.1093/gerona/glt108
31. Maggio M, Cattabiani C, Lauretani F, et al.et al. Insulin-like growth factor-1 bioactivity plays a prosurvival role in older participants. J Gerontol A Biol Sci Med Sci. 2013;68:1342-1350. DOI:10.1093/ gerona/glt045
32. Morris BJ, Donlon TA, He Q, et al.et al. Association analyses of insulin signaling pathway gene polymorphisms with healthy aging and longevity in Americans of Japanese ancestry. J Gerontol A Biol Sci Med Sci. 2014;69:270-273. DOI:10.1093/gerona/glt082
33. Nelson JF, Strong R, Bokov A, Diaz V, Ward W. Probing the relationship between insulin sensitivity and longevity using genetically modified mice. J Gerontol A Biol Sci Med Sci. 2012;67:1332-1338. DOI:10.1093/gerona/gls199
34. Novosyadlyy R, Leroith D. Insulin-like growth factors and insulin: At the crossroad between tumor development and longevity. J Gerontol A Biol Sci Med Sci. 2012;67:640-651. DOI:10.1093/gerona/gls065
35. Reddy AK, Hartley CJ, Pham TT, Darlington G, Entman ML, Taffet GE. Young little mice express a premature cardiovascular aging phenotype. J Gerontol A Biol Sci Med Sci. 2014;69:152-159. DOI:10.1093/ gerona/glt055
36. Ungvari Z, Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: Recent advances. J Gerontol A Biol Sci Med Sci. 2012;67:599-610. DOI:10.1093/gerona/gls072
37. Banki E, Sosnowska D, Tucsek Z, et al.et al. Age-Related Decline of Autocrine PACAP Impairs Angiogenic Capacity of Rat Cerebromicrovascular Endothelial Cells. J Gerontol Biol Med Sci. 2014: Doi:10.1093/gerona/glu1116. DOI:doi:10.1093/gerona/glu116
38. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011;12:723-738. DOI:10.1038/nrn3114
39. Wang YC, Colditz GA, Kuntz KM. Forecasting the obesity epidemic in the aging U.S. population. Obesity (Silver Spring). 2007;15:2855-2865. DOI:15/11/2855 [pii]10.1038/oby.2007.339
40. Gustafson DR, Karlsson C, Skoog I, Rosengren L, Lissner L, Blennow K. Mid-life adiposity factors relate to blood-brain barrier integrity in late life. J Intern Med. 2007;262:643-650. DOI:JIM1869 [pii] 10.1111/j.1365-2796.2007.01869.x
41. Beydoun MA, Beydoun HA, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-Analysis. Obes Rev. 2008;9:204-218. DOI:10.1111/j.1467-789X.2008.00473.x OBR473 [pii]
42. Wolf PA, Beiser A, Elias MF, Au R, Vasan RS, Seshadri S. Relation of obesity to cognitive function: Importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res. 2007;4:111-116.
43. Gorelick PB, Scuteri A, Black SE, et al.et al.; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672-2713. DOI:STR.0b013e3182299496 [pii] 10.1161/ STR.0b013e3182299496
44. Tucsek Z, Toth P, Sosnowsk D, et al.et al. Obesity in aging exacerbates blood brain barrier disruption, neuroinflammation and oxidative stress in the mouse hippocampus: Effects on expression of genes involved in beta-Amyloid generation and Alzheimer's disease J Gerontol Biol Med Sci. 2014: In press doi: 10.1093/gerona/glt177
45. Breese CR, Ingram RL, Sonntag WE. Influence of age and longterm dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins. J Gerontol. 1991;46:B180-B187.
46. D'Costa AP, Ingram RL, Lenham JE, Sonntag WE. The regulation and mechanisms of action of growth hormone and insulinlike growth factor 1 during normal ageing. J Reprod Fertil Suppl. 1993;46:87-98.
47. Khan AS, Sane DC, Wannenburg T, Sonntag WE. Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc Res. 2002;54:25-35. DOI:S0008636301005338 [pii]
48. Sartorio A, Cattaneo M, Bucciarelli P, et al.et al. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly. Exp Clin Endocrinol Diabetes. 2000;108:486-492. DOI:10.1055/s-2000-8145
49. Sonntag WE, Carter CS, Ikeno Y, et al.et al. Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology. 2005;146:2920-2932. DOI: 10.1210/en.2005-0058
50. Sutherland GR, Dix GA, Auer RN. Effect of age in rodent models of focal and forebrain ischemia. Stroke. 1996;27:1663-7; discussion 1668.
51. DiNapoli VA, Huber JD, Houser K, Li X, Rosen CL. Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol Aging. 2008;29:753-764. DOI:S0197-4580(06)00460-X [pii]10.1016/j.neurobiolaging.2006.12.007
52. Tan Z, Li X, Kelly KA, Rosen CL, Huber JD. Plasminogen activator inhibitor type 1 derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological function in aged rats following middle cerebral artery occlusion. Brain Res. 2009;1281:84-90. DOI:10.1016/j.brainres.2009.05.042 S0006-8993(09)00992-5 [pii]
53. Bake S, Selvamani A, Cherry J, Sohrabji F. Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-Aged female rats. PLoS One. 2014;9:e91427. DOI:10.1371/journal.pone.0091427 PONE-D-13-48985 [pii]